Olaparib and Olaparib are the same drug and there is no essential difference between them.
The main reason for the one-word difference between olaparib and olaparib is because of the translation problem, the direct translation before the market is olaparib, and the name is finalized after the market.
The indication for olaparib (olaparib) is the treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer harboring a mutation in the BRCA gene.
Common adverse reactions include gastrointestinal reactions (nausea, vomiting, diarrhea, etc.), blood and lymphatic system disorders (anemia, etc.), respiratory system (cough, etc.), and immune system (allergy).
Olaparib (Olaparib) is a commonly used prescription drug for the treatment of ovarian cancer and other diseases, please follow the doctor’s instructions for rational application.